Teva has reached a settlement with Kentucky, which will result in the dismissal of all claims against the company and its affiliates. This settlement may have a neutral short-term impact on Teva's stock price, as the payment of $1.407 million is relatively small compared to the company's overall financials. However, the resolution of legal issues can be seen as a positive development for the company.